Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 4
1983 3
1984 3
1985 3
1986 3
1987 5
1988 4
1989 7
1990 9
1991 5
1992 10
1993 16
1994 7
1995 9
1996 7
1997 10
1998 10
1999 15
2000 18
2001 13
2002 9
2003 12
2004 11
2005 14
2006 13
2007 15
2008 24
2009 19
2010 27
2011 24
2012 28
2013 26
2014 13
2015 17
2016 22
2017 12
2018 11
2019 12
2020 5
2021 15
2022 9
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

470 results

Results by year

Filters applied: . Clear all
Page 1
Synthetic immune niches for cancer immunotherapy.
Weiden J, Tel J, Figdor CG. Weiden J, et al. Among authors: figdor cg. Nat Rev Immunol. 2018 Mar;18(3):212-219. doi: 10.1038/nri.2017.89. Epub 2017 Aug 30. Nat Rev Immunol. 2018. PMID: 28853444 Review.
Tumoricidal activity of human dendritic cells.
Tel J, Anguille S, Waterborg CE, Smits EL, Figdor CG, de Vries IJ. Tel J, et al. Among authors: figdor cg. Trends Immunol. 2014 Jan;35(1):38-46. doi: 10.1016/ Epub 2013 Nov 18. Trends Immunol. 2014. PMID: 24262387 Free PMC article. Review.
Cell tracking using multimodal imaging.
Srinivas M, Melero I, Kaempgen E, Figdor CG, de Vries IJ. Srinivas M, et al. Among authors: figdor cg. Contrast Media Mol Imaging. 2013 Nov-Dec;8(6):432-8. doi: 10.1002/cmmi.1561. Contrast Media Mol Imaging. 2013. PMID: 24375899 Free article. Review.
Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.
Chiodin G, Allen JD, Bryant DJ, Rock P, Martino EA, Valle-Argos B, Duriez PJ, Watanabe Y, Henderson I, Blachly JS, McCann KJ, Strefford JC, Packham G, Geijtenbeek TBH, Figdor CG, Wright GW, Staudt LM, Burack R, Bowden TA, Crispin M, Stevenson FK, Forconi F. Chiodin G, et al. Among authors: figdor cg. Blood. 2021 Oct 28;138(17):1570-1582. doi: 10.1182/blood.2021012052. Blood. 2021. PMID: 34424958 Free PMC article.
Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis.
Weiss L, Weiden J, Dölen Y, Grad EM, van Dinther EAW, Schluck M, Eggermont LJ, van Mierlo G, Gileadi U, Bartoló-Ibars A, Raavé R, Gorris MAJ, Maassen L, Verrijp K, Valente M, Deplancke B, Verdoes M, Benitez-Ribas D, Heskamp S, van Spriel AB, Figdor CG, Hammink R. Weiss L, et al. Among authors: figdor cg. ACS Nano. 2023 Jul 11;17(13):12101-12117. doi: 10.1021/acsnano.2c11884. Epub 2023 Jun 20. ACS Nano. 2023. PMID: 37338806 Free PMC article.
Imaging of cellular therapies.
Srinivas M, Aarntzen EH, Bulte JW, Oyen WJ, Heerschap A, de Vries IJ, Figdor CG. Srinivas M, et al. Among authors: figdor cg. Adv Drug Deliv Rev. 2010 Aug 30;62(11):1080-93. doi: 10.1016/j.addr.2010.08.009. Epub 2010 Aug 25. Adv Drug Deliv Rev. 2010. PMID: 20800081 Review.
Synthetic Semiflexible and Bioactive Brushes.
Voerman D, Schluck M, Weiden J, Joosten B, Eggermont LJ, van den Eijnde T, Ignacio B, Cambi A, Figdor CG, Kouwer PHJ, Verdoes M, Hammink R, Rowan AE. Voerman D, et al. Among authors: figdor cg. Biomacromolecules. 2019 Jul 8;20(7):2587-2597. doi: 10.1021/acs.biomac.9b00385. Epub 2019 Jun 13. Biomacromolecules. 2019. PMID: 31150222 Free PMC article.
Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells.
Schluck M, Hammink R, Figdor CG, Verdoes M, Weiden J. Schluck M, et al. Among authors: figdor cg. Front Immunol. 2019 May 3;10:931. doi: 10.3389/fimmu.2019.00931. eCollection 2019. Front Immunol. 2019. PMID: 31130945 Free PMC article. Review.
Dendritic cells in cancer immunotherapy.
Le Gall CM, Weiden J, Eggermont LJ, Figdor CG. Le Gall CM, et al. Among authors: figdor cg. Nat Mater. 2018 Jun;17(6):474-475. doi: 10.1038/s41563-018-0093-6. Nat Mater. 2018. PMID: 29795222 No abstract available.
Migrating into the Tumor: a Roadmap for T Cells.
van der Woude LL, Gorris MAJ, Halilovic A, Figdor CG, de Vries IJM. van der Woude LL, et al. Among authors: figdor cg. Trends Cancer. 2017 Nov;3(11):797-808. doi: 10.1016/j.trecan.2017.09.006. Epub 2017 Nov 6. Trends Cancer. 2017. PMID: 29120755 Review.
470 results